Trevi Therapeutics Statistics
NASDAQ: TRVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.14-0.04 (-0.30%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Trevi Therapeutics by the numbers
Trevi Therapeutics has a market capitalization of $1.87 billion based on 142.48M shares outstanding. With trailing EPS of $-0.35, Trevi Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 21.2% below its 50-day average and 8.0% below its 200-day average.
Average daily trading volume is 1.91M shares, or about $25.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TRVI valuation vs. peer median
| Metric | TRVI | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.87B | $1.87B | +0% |
| Avg. volume | 1.91M | 999.10K | +91% |
Peer median across 8 companies: PVLA, AGIO, GPCR, ZYME, ADRX, SRPT, XERS, ZBIO.
Valuation
- Market cap
- $1.87B
- EPS (TTM)
- $-0.35
- Shares outstanding
- 142.48M
Price and trading
- Previous close
- 13.18
- Open
- 12.95
- Day range
- 12.84 – 13.53
- 52-week range
- 9.28 – 20.22
- 52-week change
- +37.59%
- Beta
- —
- Volume
- 5.20M
- Average volume
- 1.91M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 6, 2026
Additional statistics
- Market Cap
- 1.87B
- Forward Pe
- -22.77
- Eps
- -0.35
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 20.22
- Week52 Low
- 9.28
- Avg Volume
- 1.91M
- Shares Outstanding
- 142.48M
- Ma50
- 16.68
- Ma200
- 14.28
- Earnings Date
- Aug 6, 2026
- Pct From52w High
- -35.01%
- Pct From52w Low
- 41.59%